After analyzing subgroups of patients with highly advanced HCC (BCLC stage C/D or modified Union for International Cancer Control stage IV), it turned out that patients with MLH1 SNV detected in ctDNA had lower survival rates than those without this mutation. The gene discussed is MLH1; the disease is hepatocellular carcinoma.